Glycyl-tRNA sequestration is a unifying mechanism underlying GARS1 -associated peripheral neuropathy
Nucleic Acids Research · 20.03.2025 · 53 (6)
DOI: 10.1093/nar/gkaf201 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 22.03.2025. Verfasst von Natalia Mora und 9 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Neurobiology Laboratory, Donders Institute for Brain, Cognition and Behaviour and Faculty of Science, Radboud University, 6525AJ Nijmegen, …. Hauptthemen laut MEDLINE: Glycine-tRNA Ligase, Peripheral Nervous System Diseases, RNA, Transfer, Gly, Drosophila Proteins. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ERC, Radala Foundation, Stichting ALS Nederland.
Abstract (Originalsprache)
Dominantly inherited mutations in eight cytosolic aminoacyl-tRNA synthetase genes cause hereditary motor and sensory neuropathy, characterized by degeneration of peripheral motor and sensory axons. We previously identified a pathogenic gain-of-toxic function mechanism underlying peripheral neuropathy (PN) caused by heterozygous mutations in the GARS1 gene, encoding glycyl-tRNA synthetase (GlyRS). Specifically, PN-mutant GlyRS variants sequester tRNAGly, which depletes the cellular tRNAGly pool, leading to insufficient glycyl-tRNAGly available to the ribosome and consequently ribosome stalling at glycine codons. Given that GlyRS functions as a homodimer, a subset of PN-GlyRS mutations might alternatively cause peripheral neuropathy through a dominant negative loss-of-function mechanism. To explore this possibility, we here generated three novel PN-GlyRS Drosophila models expressing human PN-GlyRS (hGlyRS) variants that do not alter the overall GlyRS protein charge (S211F and H418R) or the single reported PN-GlyRS variant that renders the GlyRS protein charge more negative (K456Q). High-level expression of hGlyRS-K456Q did not induce peripheral neuropathy and the K456Q variant does not affect aminoacylation activity, suggesting that K456Q is not a pathogenic mutation. Expression of hGlyRS-S211F or hGlyRS-H418R in Drosophila did induce peripheral neuropathy and de novo protein synthesis defects. Genetic and biochemical evidence indicates that these phenotypes were attributable to tRNAGly sequestration rather than a dominant negative mechanism. Our data identify tRNAGly sequestration as a unifying pathogenic mechanism underlying PN-GlyRS. Thus, elevating tRNAGly levels may constitute a therapeutic approach for all PN-GlyRS patients, irrespective of their disease-causing mutation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Molecular Neurobiology Laboratory, Donders Institute for Brain, Cognition and Behaviour and Faculty of Science, Radboud University, 6525AJ Nijmegen, the Netherlands.
- Department of Biochemistry and Molecular Biology, Hamburg University, 20146 Hamburg, Germany.
ORCID-Profile: Erik Storkebaum
Förderung
- ERC
- Radala Foundation
- Stichting ALS Nederland
- AFM-Telethon
- ARSLA
- Prinses Beatrix Spierfonds
- Muscular Dystrophy Association
- Open Competition ENW-M
Zitieren
APA
Mora, N., Slot, E. F. J., Lewandowski, V., Menafra, M. P., Mallik, M., van Lith, P., Sijlmans, C., van Bakel, N., Ignatova, Z., & Storkebaum, E. (2025). Glycyl-tRNA sequestration is a unifying mechanism underlying GARS1 -associated peripheral neuropathy. Nucleic Acids Research, 53(6). https://doi.org/10.1093/nar/gkaf201
Vancouver
Mora N, Slot EFJ, Lewandowski V, Menafra MP, Mallik M, van Lith P, et al. Glycyl-tRNA sequestration is a unifying mechanism underlying GARS1 -associated peripheral neuropathy. Nucleic Acids Research. 2025;53(6). doi:10.1093/nar/gkaf201
BibTeX
@article{Mora2025,
author = {Mora, Natalia and Slot, Erik F J and Lewandowski, Vanessa and Menafra, Maria P and Mallik, Moushami and van Lith, Pascal and Sijlmans, Céline and van Bakel, Nick and Ignatova, Zoya and Storkebaum, Erik},
title = {Glycyl-tRNA sequestration is a unifying mechanism underlying GARS1 -associated peripheral neuropathy},
journal = {Nucleic Acids Research},
year = {2025},
volume = {53},
number = {6},
doi = {10.1093/nar/gkaf201}
}
EUVIMED